Dauch Corporation (DCH)

NYSEConsumer DiscretionaryAuto - PartsSnapshot 2026-10-23

$4.63-1.28%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Dauch Corporation’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

-2.4%

+10% or more+5%0%−5%−10% or less

1.22 → 1.19 EPS · FY ending Dec 31, 2027 · 7 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 7 to 7; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q4
Revenue	—	2.57B
EPS	—	0.111
FY 2026 · Annual
Revenue	$10.6B–$10.8B	10.71B
EPS	—	0.913
EBITDA	$1.36B–$1.43Bnon-GAAP $995M–$1.06B	—
Free cash flow	$260M–$325Mnon-GAAP -$105M–-$90M	—
Operating cash flow	$395M–$410M	—
FY 2027 · Annual
Revenue	—	11.04B
EPS	—	1.187

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Achieve positive adjusted free cash flow	A primary condition in Dauch Corporation's published investment case. The stated target is Adjusted free cash flow >= $235M in FY26.	Improving	adjusted free cash flow remains negative or below $235M in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Adjusted free cash flow was negative $40.8M in 2026-Q1 but improved to positive $148.4M in 2026-Q2. Management maintains a full year 2026 target range of $235M to $325M, showing progress but still early in the year to fully deliver. Delivery assessment Oct 24, 2026
Improvement in gross profit margins	Gross profit improved by $51.5 million, showing better margins.	Improving	gross profit margin falls below 2025-Q1 levels sustainably	Gross margin: 11.44% FY2026-Q2; GAAP. Published target: Maintain or improve gross profit margin relative to 2026-Q1 levels. Target percentage unit is not explicit. Source published Aug 7, 202611.442685 percent · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: b115c25d-5006-44ae-b7c9-fcec1d98067f. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Adjusted EBITDA margin improved from 12.2% in 2025-Q4 to 13.2% in 2026-Q2, reflecting synergy benefits and operational improvements. Management's focus on margin enhancement is delivering gradual progress. Delivery assessment Oct 24, 2026
Revenue growth driven by Dowlais acquisition	Dauch Corporation is growing revenue fast, boosted by the Dowlais acquisition.	Intact	total revenue falls below $10.3B in FY26	Revenue: $2.956B FY2026-Q2; GAAP. Published target: >= $10.55B total revenue in FY26. Target period is not explicitly aligned with this observation. Source published Aug 7, 20262,955,600,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: b115c25d-5006-44ae-b7c9-fcec1d98067f. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Revenue grew from $1.41B in 2025-Q1 to $2.38B in 2026-Q1 and further to $2.96B in 2026-Q2, driven by the Dowlais acquisition. Management consistently emphasizes unlocking Dowlais's strategic potential, and the trajectory is delivering significant revenue growth. Delivery assessment Oct 24, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$1.19

$1.07 → $1.19 · observed estimates

FY2027 revenue$11.04B

$10.96B → $11.04B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$1.07	$10,962,097,686	7 / 8
2026-07-25	$1.07	$10,962,097,686	7 / 8
2026-07-26	$1.07	$10,962,097,686	7 / 8
2026-07-27	$1.07	$10,962,097,686	7 / 8
2026-07-28	$1.07	$10,962,097,686	7 / 8
2026-07-29	$1.07	$10,962,097,686	7 / 8
2026-07-30	$1.07	$10,962,097,686	7 / 8
2026-07-31	$1.08	$10,971,303,820	11 / 10
2026-08-01	$1.07	$10,962,097,686	7 / 8
2026-08-02	$1.08	$10,971,303,820	11 / 10
2026-08-03	$1.07	$10,962,097,686	6 / 8
2026-08-04	$1.07	$10,962,097,686	6 / 8
2026-08-05	$1.08	$10,971,303,820	11 / 10
2026-08-06	$1.08	$10,971,303,820	11 / 10
2026-08-07	$1.07	$10,962,097,686	6 / 8
2026-08-08	$1.08	$10,971,303,820	11 / 10
2026-08-09	$1.08	$10,971,303,820	11 / 10
2026-08-10	$1.07	$10,962,097,686	6 / 8
2026-08-11	$1.09	$10,978,120,230	11 / 8
2026-08-12	$1.07	$10,962,097,686	6 / 8
2026-08-13	$1.07	$10,962,097,686	6 / 8
2026-08-14	$1.07	$10,962,097,686	6 / 8
2026-08-15	$1.07	$10,962,097,686	7 / 8
2026-08-16	$1.07	$10,962,097,686	7 / 8
2026-08-17	$1.07	$10,962,097,686	7 / 8
2026-08-18	$1.07	$10,962,097,686	7 / 8
2026-08-19	$1.07	$10,962,097,686	7 / 8
2026-08-20	$1.19	$11,039,647,834	7 / 9
2026-08-21	$1.19	$11,039,647,834	7 / 9
2026-08-22	$1.19	$11,039,647,834	7 / 9
2026-08-23	$1.19	$11,039,647,834	7 / 9
2026-08-24	$1.19	$11,039,647,834	7 / 9
2026-08-25	$1.19	$11,039,647,834	7 / 9
2026-08-26	$1.19	$11,039,647,834	7 / 9
2026-08-27	$1.19	$11,039,647,834	7 / 9
2026-08-28	$1.19	$11,039,647,834	7 / 9
2026-08-29	$1.19	$11,056,612,617	7 / 9
2026-08-30	$1.19	$11,056,612,617	7 / 9
2026-08-31	$1.19	$11,056,612,617	7 / 9
2026-09-01	$1.19	$11,056,612,617	7 / 9
2026-09-02	$1.19	$11,056,612,617	7 / 9
2026-09-03	$1.19	$11,056,612,617	7 / 9
2026-09-04	$1.19	$11,056,612,617	7 / 9
2026-09-05	$1.19	$11,056,612,617	7 / 9
2026-09-06	$1.19	$11,056,612,617	7 / 9
2026-09-07	$1.19	$11,056,612,617	7 / 9
2026-09-08	$1.19	$11,056,612,617	7 / 9
2026-09-09	$1.21	$11,066,782,617	7 / 9
2026-09-10	$1.21	$11,055,284,197	7 / 9
2026-09-11	$1.21	$11,055,284,197	7 / 9
2026-09-12	$1.21	$11,055,284,197	7 / 9
2026-09-13	$1.21	$11,055,284,197	7 / 9
2026-09-14	$1.21	$11,055,284,197	7 / 9
2026-09-15	$1.21	$11,055,284,197	7 / 9
2026-09-16	$1.21	$11,055,284,197	7 / 9
2026-09-17	$1.21	$11,055,284,197	7 / 9
2026-09-18	$1.21	$11,055,284,197	7 / 9
2026-09-19	$1.21	$11,055,284,197	7 / 9
2026-09-20	$1.21	$11,055,284,197	7 / 9
2026-09-21	$1.21	$11,055,284,197	7 / 9
2026-09-22	$1.21	$11,055,284,197	7 / 9
2026-09-23	$1.22	$11,064,595,902	7 / 9
2026-09-24	$1.22	$11,064,595,902	7 / 9
2026-09-25	$1.22	$11,064,595,902	7 / 9
2026-09-26	$1.22	$11,064,595,902	7 / 9
2026-09-27	$1.22	$11,064,595,902	7 / 9
2026-09-28	$1.22	$11,064,595,902	7 / 9
2026-09-29	$1.22	$11,064,595,902	7 / 9
2026-09-30	$1.22	$11,064,595,902	7 / 9
2026-10-01	$1.22	$11,064,595,902	7 / 10
2026-10-02	$1.22	$11,064,595,902	7 / 10
2026-10-03	$1.21	$11,070,149,203	7 / 10
2026-10-04	$1.21	$11,070,149,203	7 / 10
2026-10-05	$1.21	$11,070,149,203	7 / 10
2026-10-06	$1.21	$11,070,149,203	7 / 10
2026-10-07	$1.21	$11,070,149,203	7 / 10
2026-10-08	$1.19	$11,067,621,696	7 / 10
2026-10-09	$1.19	$11,067,621,696	7 / 10
2026-10-10	$1.19	$11,067,621,696	7 / 10
2026-10-11	$1.18	$11,066,194,423	7 / 10
2026-10-12	$1.18	$11,066,194,423	7 / 10
2026-10-13	$1.18	$11,066,194,423	7 / 10
2026-10-14	$1.17	$11,066,194,423	7 / 10
2026-10-15	$1.16	$11,066,194,423	7 / 9
2026-10-16	$1.17	$11,058,183,177	7 / 9
2026-10-17	$1.17	$11,058,183,177	7 / 9
2026-10-18	$1.17	$11,058,183,177	7 / 9
2026-10-19	$1.17	$11,058,183,177	7 / 9
2026-10-20	$1.16	$11,041,464,995	7 / 9
2026-10-21	$1.16	$11,041,464,995	7 / 9
2026-10-22	$1.16	$11,041,464,995	7 / 9
2026-10-23	$1.19	$11,041,464,995	7 / 9
2026-10-24	$1.19	$11,041,464,995	7 / 9

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	6	5	0
2026-06-01	6	6	0
2026-07-01	6	7	0
2026-08-01	6	7	0
2026-09-01	7	7	0
2026-10-01	6	7	1

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 6 Buy / Strong Buy · 7 Hold · 1 Sell / Strong Sell

0 upgrades0 downgrades3 maintains

Recent actions · Sep 25–Oct 24 · 3 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

BarclaysOct 9 · prior Aug 17

$9.00 → $8.00-11.1%

UBSOct 7 · prior Jul 9

$9.00 → $8.00-11.1%

$0$4.95$9.90

0 raises · 2 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Achieve positive adjusted free cash flowDirect metric needs a verified mapping
Improvement in gross profit marginsGross margin: 11.44%
Revenue growth driven by Dowlais acquisitionRevenue: $2.956B

Next proof point

Nov 6, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

2.4%Typical daily move · historical

Downside history

-48.6%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Dauch Corporation outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is an acquisition-led business improvement story, not yet a proven durable compounder, because the evidence still describes earnings quality as loss-making. The multi-year view is on watch: the signal recently improved from mixed to mildly favorable, but results remain below the industry cohort.

What's priced into Dauch Corporation

DCH is described as cheap versus peers, while the valuation model also indicates a peer premium, leaving the relative valuation picture mixed. The priced-in tag is justified, with low fragility, but the negative expectations gap suggests the market’s assumptions remain cautious; confidence in that reading is medium.

What the fundamentals likely do

Near term, revenue growth has been strong, mainly because of the Dowlais acquisition, and adjusted free cash flow improved from negative in the first quarter to positive in the second. Reaching management’s full-year cash flow target remains unproven, although capital spending is tracking its stated range. A recent earnings beat and guidance raise support the picture, while the CFO transition and risk of a later guidance reversal are important uncertainties.

What Dauch Corporation hinges on

Over the next few quarters, the key test is whether DCH sustains cash generation and delivers its 2026 cash flow target without reversing its recent guidance raise. Sector signals also matter: continued strong results from GPC, BWA, and APTV could support the sector backdrop, while misses or lower guidance could weaken it. The evidence on these forward scenarios is limited, so the thesis remains conditional.